Cancer diagnostics

cancer target detection radiopharma radio

Fierce Biotech

Tempus buys out Personalis in $1.5 billion deal

Tempus is boosting its cancer offerings with a deal to buy out Personalis three years after the pair first teamed up in oncology.

Ben Adams Jul 20, 2026 9:55am

A magnifying glass focuses an AI chip icon with healthcare symbols on blue background

Weekly Rundown: SpotitEarly partners with HITLAB

Jul 17, 2026 2:30pm